Recent research highlights potential links between the Epstein-Barr virus and Multiple Sclerosis, advancements in MS treatment development by Quantum BioPharma Ltd., efforts by the American Heart Association to integrate food as medicine interventions, the need for multi-antigen COVID-19 vaccines by GeoVax Labs, Inc., business updates from BioCorRx Pharmaceuticals Inc., insights from a multidisciplinary study on the 2025 Myanmar earthquake, upcoming webinars by Creative Biolabs on neural circuits and bispecific antibodies, and a study emphasizing the impact of sedentary behavior on cardiovascular health after a heart attack.